[Position statement of the Hungarian Radiotherapy and Oncology College on the insurance coverage of Ratiograstim (biocompatible filgrastim)].
Pikó
Béla
B
Békés Megyei Képviselotestület Pándy Kálmán Kórháza Megyei Onkológiai Központ 5700 Gyula Semmelweis u. 1.
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001672:Biocompatible Materials / Q000008:administration & dosage / Q000191:economics*; D005334:Fever / Q000209:etiology / Q000517:prevention & control; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage / Q000191:economics*; D006801:Humans; D006814:Hungary; D019458:Insurance Coverage; D009503:Neutropenia / Q000139:chemically induced / Q000188:drug therapy* / Q000517:prevention & control; D011994:Recombinant Proteins; D012955:Societies, Medical
D000970:Antineoplastic Agents; D001672:Biocompatible Materials; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D000069585:Filgrastim